These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 775438)

  • 41. [Clinical pharmacology 1969].
    Szórády I
    Orv Hetil; 1969 Mar; 110(10):517-22. PubMed ID: 4888738
    [No Abstract]   [Full Text] [Related]  

  • 42. [P-450 cytochromes and mono-oxygenases. Mechanism of action. Consequences in pharmacology and toxicology (author's transl)].
    Mansuy D
    Ann Biol Clin (Paris); 1980; 38(1):19-23. PubMed ID: 7377646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Future of toxicology-metabolic activation and drug design: challenges and opportunities in chemical toxicology.
    Baillie TA
    Chem Res Toxicol; 2006 Jul; 19(7):889-93. PubMed ID: 16841955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Towards a more rational regulation of the development of new medicines. Report of a European workshop held in Sestri Levante, Italy, September 28-30, 1976.
    Eur J Clin Pharmacol; 1977 Mar; 11(3):233-8. PubMed ID: 852499
    [No Abstract]   [Full Text] [Related]  

  • 45. [Dependence of the therapeutic and toxic effects of a drug on its fate in the body].
    Remmer H
    Anglo Ger Med Rev; 1965 Nov; 3(1):5-12. PubMed ID: 5855240
    [No Abstract]   [Full Text] [Related]  

  • 46. Idiosyncratic toxicity: mechanistic insights gained from analysis of prior compounds.
    Waring JF; Anderson MG
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):59-65. PubMed ID: 15679173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complicating factors in safety testing of drug metabolites: kinetic differences between generated and preformed metabolites.
    Prueksaritanont T; Lin JH; Baillie TA
    Toxicol Appl Pharmacol; 2006 Dec; 217(2):143-52. PubMed ID: 17055014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans.
    Masubuchi N; Makino C; Murayama N
    Chem Res Toxicol; 2007 Mar; 20(3):455-64. PubMed ID: 17309281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Introduction to toxicology: methods for the determination of toxicity of substances. II].
    Reith JF
    Pharm Weekbl; 1969 Oct; 104(44):1373-85. PubMed ID: 5352088
    [No Abstract]   [Full Text] [Related]  

  • 50. International Symposium on Clinical Pharmacology. Introduction.
    Smahel O
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):3-5. PubMed ID: 4924327
    [No Abstract]   [Full Text] [Related]  

  • 51. Reactive metabolites as key intermediates in pharmacologic and toxicologic responses: examples from chemical carcinogenesis.
    Miller EC; Miller JA
    Adv Exp Med Biol; 1981; 136 Pt A():1-21. PubMed ID: 7344452
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pharmacodynamic study of new drugs].
    Díaz López N
    Rev Sanid Hig Publica (Madr); 1970 May; 44(5):555-98. PubMed ID: 5495955
    [No Abstract]   [Full Text] [Related]  

  • 53. Relay residue studies: a modification of the relay toxicity approach.
    Craine EM
    J Toxicol Environ Health; 1977 Mar; 2(4):905-7. PubMed ID: 853545
    [No Abstract]   [Full Text] [Related]  

  • 54. [Liver lesions caused by drugs and environmental pollutants. Free radicals and reactive metabolites. I].
    Mariani L; Baratelli M
    Clin Ter; 1982 Nov; 103(3):237-65. PubMed ID: 7151380
    [No Abstract]   [Full Text] [Related]  

  • 55. Geriatric medications: how the aged are hurt by drugs meant to help.
    Hanan ZI
    RN; 1978 Jan; 41(1):57-61. PubMed ID: 244994
    [No Abstract]   [Full Text] [Related]  

  • 56. The use of theoretical pharmacokinetic concepts in studies of the mechanisms of formation of chemically reactive metabolites in vitro and in vivo.
    Gillette JR
    Drug Metab Rev; 1983; 14(1):9-33. PubMed ID: 6839943
    [No Abstract]   [Full Text] [Related]  

  • 57. Molecules in food that alter drug metabolism.
    Mclean AE
    Proc Nutr Soc; 1974 Dec; 33(3):197-202. PubMed ID: 4459963
    [No Abstract]   [Full Text] [Related]  

  • 58. The interaction of intercalating drugs with nucleic acids.
    Berman HM; Young PR
    Annu Rev Biophys Bioeng; 1981; 10():87-114. PubMed ID: 7020585
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug conjugation in clinical toxicology.
    Prescott LF
    Biochem Soc Trans; 1984 Feb; 12(1):96-9. PubMed ID: 6705998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pro-drugs].
    Machoń Z
    Postepy Hig Med Dosw; 1979; 33(4):345-75. PubMed ID: 514925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.